Shares of Mustang Bio ( NASDAQ: MBIO) jumped on Monday after the company said that the U.S. FDA has granted orphan drug ...

At its second attempt, Astellas won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for claudin 18.2+ gastric cancer ...

MSD will soon enter the market for drugs used to protect infants from respiratory syncytial virus (RSV) infections after getting approval from the FDA for its antibody therapy Enflonsia. The green ...